Difference between revisions of "Sertraline-venlafaxine"

From Psychiatrienet
Jump to: navigation, search
Line 11: Line 11:
 
| caveat =
 
| caveat =
 
* Occurrence of the serotonin syndrome is theoretically possible.
 
* Occurrence of the serotonin syndrome is theoretically possible.
{{caveSS}}
 
  
 
}}
 
}}

Revision as of 08:20, 20 July 2009

Sertraline
Type Antidepressant
Group SSRI
links
Medscape Sertraline
PubChem 68617
PubMed Sertraline
Kompas (Dutch) Sertraline
Wikipedia Sertraline
Venlafaxine
Type Antidepressant
Group SNRI
links
Medscape Venlafaxine
PubChem 5656
PubMed Venlafaxine
Kompas (Dutch) Venlafaxine
Wikipedia Venlafaxine

Switch medication from sertraline to venlafaxine.[1] [2]

Nietinrijdenbord.png Stop sertraline
  • Before day 0: gradually reduce dosage of sertraline to a maximum of 50 mg/ day, when this dosage is > 50 mg/day.
  • Day 1: reduce dosage of sertraline to 25 mg/day.
  • Day 8: stop administration of sertraline.
Eenrichtingbord.png Start venlafaxine
  • No wash-out period is needed.
  • Day 9: Start administration of venlafaxine in a normal dosage of 37,5 mg or 75 mg (slow release) /day.
Letopbord.png Cave
  • Occurrence of the serotonin syndrome is theoretically possible.


  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.